HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,446,251 | +45.0% | 27,308 | +37.8% | 0.00% | +100.0% |
| Q2 2023 | $1,687,305 | +49.9% | 19,818 | +41.1% | 0.00% | 0.0% |
| Q1 2023 | $1,125,827 | +9.9% | 14,043 | +7.8% | 0.00% | 0.0% |
| Q4 2022 | $1,024,495 | +28.4% | 13,026 | +20.9% | 0.00% | 0.0% |
| Q3 2022 | $798,000 | +45.4% | 10,778 | +28.0% | 0.00% | – |
| Q2 2022 | $549,000 | -50.1% | 8,422 | -51.6% | 0.00% | -100.0% |
| Q1 2022 | $1,100,000 | +214.3% | 17,407 | +163.5% | 0.00% | – |
| Q4 2021 | $350,000 | -2.5% | 6,605 | +29.9% | 0.00% | – |
| Q3 2021 | $359,000 | +20.5% | 5,084 | +13.6% | 0.00% | – |
| Q2 2021 | $298,000 | -16.8% | 4,477 | +38.7% | 0.00% | – |
| Q1 2021 | $358,000 | -99.7% | 3,227 | -99.7% | 0.00% | -100.0% |
| Q3 2019 | $116,785,000 | +5.5% | 925,833 | +0.7% | 0.12% | +6.4% |
| Q2 2019 | $110,677,000 | +51.6% | 919,706 | +10.2% | 0.11% | +48.6% |
| Q1 2019 | $73,029,000 | -5.9% | 834,811 | +7.6% | 0.07% | -16.9% |
| Q4 2018 | $77,634,000 | -32.6% | 775,955 | -22.9% | 0.09% | -20.5% |
| Q3 2018 | $115,243,000 | +323.0% | 1,005,784 | +231.1% | 0.11% | +314.8% |
| Q2 2018 | $27,246,000 | +211.7% | 303,808 | +154.3% | 0.03% | +200.0% |
| Q1 2018 | $8,741,000 | -22.0% | 119,484 | -38.1% | 0.01% | -18.2% |
| Q4 2017 | $11,210,000 | +402.7% | 193,013 | +288.3% | 0.01% | +450.0% |
| Q3 2017 | $2,230,000 | +22.1% | 49,704 | +7.4% | 0.00% | 0.0% |
| Q2 2017 | $1,827,000 | -1.8% | 46,271 | +0.9% | 0.00% | 0.0% |
| Q1 2017 | $1,860,000 | +1.8% | 45,846 | +0.9% | 0.00% | 0.0% |
| Q4 2016 | $1,827,000 | -75.6% | 45,441 | -82.4% | 0.00% | -77.8% |
| Q2 2016 | $7,493,000 | -62.3% | 258,474 | -54.5% | 0.01% | -60.9% |
| Q1 2016 | $19,880,000 | +4.0% | 568,318 | -4.2% | 0.02% | +4.5% |
| Q4 2015 | $19,119,000 | +16.1% | 593,020 | +16.4% | 0.02% | +10.0% |
| Q3 2015 | $16,469,000 | -19.5% | 509,546 | +3.1% | 0.02% | -13.0% |
| Q2 2015 | $20,450,000 | -19.4% | 494,430 | -12.5% | 0.02% | -17.9% |
| Q1 2015 | $25,382,000 | -19.3% | 565,040 | -32.8% | 0.03% | -20.0% |
| Q4 2014 | $31,463,000 | -6.4% | 840,818 | -12.7% | 0.04% | -10.3% |
| Q3 2014 | $33,618,000 | +4.0% | 962,723 | +5.0% | 0.04% | +5.4% |
| Q2 2014 | $32,333,000 | +433.6% | 916,465 | +393.0% | 0.04% | +428.6% |
| Q1 2014 | $6,059,000 | +236.2% | 185,905 | +311.5% | 0.01% | +250.0% |
| Q3 2013 | $1,802,000 | -37.5% | 45,180 | -35.2% | 0.00% | -50.0% |
| Q2 2013 | $2,885,000 | – | 69,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |